AGIO: Insider reports 2,959 RSUs vesting

AGIO Therapeutics reported a notice under Rule 144 for common stock related to an insider transaction.

Rhea-AI Filing Summary

AGIO Therapeutics reported a notice under Rule 144 for common stock related to an insider transaction. The filing shows 2,959 shares tied to the vesting of Restricted Stock Units on 04/02/2026. The filing also records that Krishnan Viswanadhan had 2,959 shares listed under "Securities Sold During The Past 3 Months" with an associated dollar figure of $82,260.00 dated 03/05/2026.

Insights

Insider Transactions Analyst

Notice records RSU vesting and a recent sale by an affiliate.

The filing lists 2,959 shares vesting as Restricted Stock Units on 04/02/2026, and a prior entry showing 2,959 shares sold on 03/05/2026 with $82,260.00 noted. This is a routine Rule 144 notice of an affiliate transaction rather than a corporate action.

Timing and cash‑flow detail beyond the listed amounts are not provided in the excerpt; subsequent filings or trade reports would show market execution details if relevant.

Key Figures

RSUs vesting: 2,959 shares Past sale shares: 2,959 shares Dollar figure shown: $82,260.00 +2 more

5 metrics

RSUs vesting 2,959 shares vesting on 04/02/2026

Past sale shares 2,959 shares sale dated 03/05/2026

Dollar figure shown $82,260.00 associated with 03/05/2026 sale entry

Filing form Form 144 Rule 144 notice of proposed sale

Exchange Nasdaq listed exchange in the excerpt

Key Terms

Restricted Stock Units, Rule 144, Securities Sold During The Past 3 Months

3 terms

Restricted Stock Units financial

"Vesting of Restricted Stock Units on 04/02/2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Rule 144 regulatory

"Form 144 notice for common stock transactions"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Securities Sold During The Past 3 Months financial

"Entry showing 03/05/2026 sale of 2,959 shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does AGIO's Form 144 show about RSU vesting?

It shows 2,959 shares vesting as Restricted Stock Units on 04/02/2026. The entry is recorded as an issuer-related vesting event tied to common stock.

Did an AGIO insider report recent sales?

Yes. The filing lists Krishnan Viswanadhan with 2,959 shares under "Securities Sold During The Past 3 Months" dated 03/05/2026, with $82,260.00 shown.

Does the Form 144 state proceeds go to AGIO?

The excerpt does not explicitly state proceeds treatment. It records a dollar figure $82,260.00 alongside a past sale date but does not allocate proceeds in the excerpt.

Is this Form 144 an indication of secondary offering for AGIO?

No. This filing records an affiliate transaction (vesting and a past sale) under Rule 144, not a company-initiated public offering or shelf registration.

Who is the reporting party on the filing for AGIO?

The filing lists Krishnan Viswanadhan with an address in Cambridge, MA, associated with the listed common stock entries and the RSU vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:05 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001999913
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AGIOS PHARMACEUTICALS, INC.
SEC File Number	001-36014
Address of Issuer	88 SIDNEY STREET CAMBRIDGE MASSACHUSETTS 02139
Phone	617-649-8600
Name of Person for Whose Account the Securities are To Be Sold	Viswanadhan Krishnan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2959	101168.00	58592172	04/02/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	04/02/2026	Vesting of Restricted Stock Units	Issuer			2959	04/02/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Krishnan Viswanadhan 88 Sidney Street Cambridge MA 02139	Common Stock	03/05/2026	2959	82260.00

144: Remarks and Signature

Remarks
Date of Notice	04/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/05/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	William Cook, attorney-in-fact for Krishnan Viswanadhan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)